PKBK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. The chart is extended (RSI ~68) and nearing resistance (R1 ~27.82) while momentum is starting to cool (MACD histogram still positive but contracting). Add heavy insider selling (+174.94% MoM) and a weak short-term statistical outlook (higher odds of mild declines over 1D/1W/1M), and the risk/reward for entering immediately is unattractive despite strong recent financial growth.
Trend remains bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend. Momentum is positive but decelerating: MACD histogram at 0.142 above zero but contracting, suggesting upside is losing steam. RSI_6 at 68.444 is close to overbought, implying limited near-term upside without consolidation. Key levels: Pivot 26.582 (first support), S1 25.344; resistance at R1 27.82 then R2 28.584. With pre-market at 27.14, price is closer to resistance than support, making the immediate entry less compelling. Pattern-based forward view is slightly negative: ~60% chance of -0.54% next day, -1.22% next week, -1.82% next month.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
growth: revenue +39.46% YoY to 22.253M, net income +49.84% YoY to 11.079M, EPS +52.46% YoY to 0.
Technically, the stock remains in a confirmed uptrend (bullish moving averages). Options open interest is heavily call-skewed (bullish positioning), albeit illiquid.
than support (pivot 26.582). No news catalysts in the past week to justify chasing strength. Short-horizon pattern model leans slightly negative over 1D/1W/1M. Options show very high IV versus HV, implying elevated uncertainty or expensive option pricing.
2025/Q4 showed clear acceleration: Revenue 22.253M (+39.46% YoY), Net Income 11.079M (+49.84% YoY), EPS 0.93 (+52.46% YoY). Overall, fundamentals in the latest quarter look strong and improving, supporting the longer-term uptrend, but they don’t override the current extended technical setup and insider selling for an immediate buy.
No analyst rating or price target change data was provided, so no recent trend in Wall Street upgrades/downgrades or target revisions can be confirmed. Net pros/cons view from analysts cannot be reliably assessed from the current dataset. Politician/congress trading: no recent congress trading data available in the last 90 days.
